Loading stock data…
MCK
$789.75+5.53 (+0.70%)
Market OpenUpdated 1:33 PM EDT
McKesson Corporation provides healthcare services in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
McKesson Corporation in the Healthcare sector is trading at $789.75 with a market capitalization of $90.7B. Wall Street consensus targets $941.40 (15 analysts), implying a +19.2% move over the next 12 months. The stock is currently 21% below its 52-week high of $999.00, remaining 3.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $96.30B↓ | $106.16B↑ | $103.15B↑ | $97.83B↑ | $90.82B |
| Gross Profit | $4.04B↑ | $3.69B↑ | $3.54B↑ | $3.28B↓ | $3.64B |
| Operating Income | $2.25B↑ | $1.66B↑ | $1.47B↑ | $1.08B↓ | $1.66B |
| Net Income | $1.68B↑ | $1.19B↑ | $1.11B↑ | $784.00M↓ | $1.26B |
Peer Comparison
JNJUNHPFE
Fundamentals
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Phar...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$90.72B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.65
Beta
Defensive asset. Lower volatility than the S&P 500.
0.35
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.40%
ROE
Average efficiency. Growth may require heavy reinvestment.
-334.36%
Volume
Today's trading volume
332,234
Recent News
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.
McKesson (MCK) Valuation Check After Recent Share Price Rebound And Mixed Fundamental Signals
McKesson stock reaction and recent performance snapshot McKesson (MCK) has drawn investor attention after recent price moves, with the stock up about 4% over the past week and about 4% over the past month, despite a roughly 16% decline over the past 3 months. Against this backdrop, the share price recently closed at US$775.66. The company reported revenue of US$403.43b and net income of US$4.76b, giving investors a large, established healthcare distributor to assess. See our latest analysis...
Here is What Analysts Are Saying About McKesson Corporation (MCK)
McKesson Corporation (NYSE:MCK) is one of top cheap stocks with Strong Buy ratings on Wall Street. Citi cut the price target on McKesson Corporation (NYSE:MCK) to $945 from $975 on May 14 and reiterated a Buy rating on the shares. The company also received a rating update from BofA on May 8, with the firm […]
3 Cash-Producing Stocks with Promising Prospects
Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions.